CDK
Cyclin dependent kinase
CDKs (Cyclin-dependent kinases) are serine-threonine kinases first discovered for their role in regulating the cell cycle. They are also involved in regulating transcription, mRNA processing, and the differentiation of nerve cells. CDKs are relatively small proteins, with molecular weights ranging from 34 to 40 kDa, and contain little more than the kinase domain. In fact, yeast cells can proliferate normally when their CDK gene has been replaced with the homologous human gene. By definition, a CDK binds a regulatory protein called a cyclin. Without cyclin, CDK has little kinase activity; only the cyclin-CDK complex is an active kinase.
There are around 20 Cyclin-dependent kinases (CDK1-20) known till date. CDK1, 4 and 5 are involved in cell cycle, and CDK 7, 8, 9 and 11 are associated with transcription.
CDK levels remain relatively constant throughout the cell cycle and most regulation is post-translational. Most knowledge of CDK structure and function is based on CDKs of S. pombe (Cdc2), S. cerevisia (CDC28), and vertebrates (CDC2 and CDK2). The four major mechanisms of CDK regulation are cyclin binding, CAK phosphorylation, regulatory inhibitory phosphorylation, and binding of CDK inhibitory subunits (CKIs).
CDK Isoform Specific Products
-
CDK
(486)
View all products
-
CDK1
(198)
View all products
-
CDK2
(316)
View all products
-
CDK3
(28)
View all products
-
CDK4
(236)
View all products
-
CDK5
(98)
View all products
-
CDK6
(179)
View all products
-
CDK7
(119)
View all products
-
CDK8
(57)
View all products
-
CDK9
(206)
View all products
-
CDK11
(9)
View all products
-
CDK12
(54)
View all products
-
CDK13
(28)
View all products
-
CDK14
(6)
View all products
-
CDK16
(8)
View all products
-
CDK19
(25)
View all products
-
CDC
(21)
View all products
-
CLK
(31)
View all products
-
Pho85
(1)
View all products
-
CDK10
(1)
View all products
-
CDK15
(1)
View all products
-
CDK17
(2)
View all products
-
CDK18
(1)
View all products
-
CDK20
(1)
View all products
-
PITSLRE
(1)
View all products
All Product Categories
-
CDK Inhibitors
(1088)
View all products
-
CDK Agonists
(3)
View all products
-
CDK Antagonists
(2)
View all products
-
CDK Activators
(18)
View all products
-
CDK Modulators
(15)
View all products
-
CDK Degraders
(95)
View all products
-
CDK Controls
(4)
View all products
-
CDK Substrate
(1)
View all products
-
CDK Ligands
(16)
View all products
-
Cyclin-Dependent Kinases (CDKs) Proteins
(80)
View all products
-
Cyclin Dependent Kinase 1 (CDK1) Proteins
(9)
View all products
-
Cyclin-Dependent Kinase 2 (CDK2) Proteins
(12)
View all products
-
Cyclin-Dependent Kinase 3 (CDK3) Proteins
(6)
View all products
-
Cyclin-Dependent Kinase 4 (CDK4) Proteins
(4)
View all products
-
Cyclin-Dependent Kinase 5 (CDK5) Proteins
(5)
View all products
-
Cyclin-Dependent Kinase 6 (CDK6) Proteins
(6)
View all products
-
Cyclin-Dependent Kinase 7 (CDK7) Proteins
(4)
View all products
-
CDK Produits associés (1364)
Produits associés (1364)
-
Protéines Recombinantes (82)
-
Anticorps (42)
-
CDK Isoform Comparison
-
Eriocalyxin B
0 ImagesEriocalyxin B is a diterpenoid compound that can be isolated from Chinese herb Isodon eriocalyx. Eriocalyxin B exhibits multiple activities, such as anti-cancer, anti-inflammatory, and inhibition of adipogenesis. Eriocalyxin B is capable of inducing apoptosis and autophagy in tumor cells. Eriocalyxin B can be used in the research of cancers, autoimmune diseases, and other conditions. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
N9-Isopropylolomoucine
0 ImagesN9-Isopropylolomoucine is a mitotic cyclin dependent kinase (CDK) inhibitor. N9-Isopropylolomoucine targets CCNB 1/CDK1 and can be used for cancer research. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- AT7519 TFA
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
CDK9/EZH2-IN-1
0 ImagesCDK9/EZH2-IN-1 (Compound D16) is a CDK9/EZH2 dual-target inhibitor (IC50: 83.9/108.6 nM). CDK9/EZH2-IN-1 induces apoptosis and DNA double-strand breaks (DSBs). CDK9/EZH2-IN-1 inhibits the proliferation activity of MKN45, MDA-MB-453 and SW620 cancer cells (IC50 values are 136.3, 171.3 and 315.7 nM, respectively). -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- CDK2/MDM2-IN-1
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
CDK4/6-IN-12
0 ImagesCDK4/6-IN-12 is a potent cyclin-dependent kinase 4/6 (CDK4/6) inhibitor. CDK4/6-IN-12 has enzymatic inhibitory activity for CDK4 and CDK6 with IC50 of 592.3 nM and 3090 nM, respectively. CDK4/6-IN-12 can be used for the research of cancer. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- CDK1-IN-6
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Bisindolylmaleimide III
0 ImagesBisindolylmaleimide III is a protein kinase C (PKC) inhibitor with IC50 values of 0.26, 5.7, and 6 μM against PKCα, PKCδ, and PKCμ, respectively. Bisindolylmaleimide III also exhibits inhibitory activity against other off-targets, with IC50 values of 0.17, 1, and 2 μM against SLK, adenosine kinase (AK), and CDK2, respectively; its Ki for NQO2 is 16.5 μM. Bisindolylmaleimide III selectively binds to activated Rsk1 following EGF stimulation, and serves as a tool for detecting the activation status of intracellular Rsk1 and PKCα, as well as for functional analysis of SLK. Bisindolylmaleimide III can be used in studies of signal transduction and colorectal cancer. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
CDK12-IN-5
0 ImagesCDK12-IN-5, a pyrazolotriazine, is a potent CDK12 inhibitor with an IC50 of 23.9 nM at high ATP (2 mM). CDK12-IN-5 has no effect on CDK2/Cyclin E (IC50=173 μM) and CDK9/Cyclin T1 (IC50=127 μM) at high ATP (2 mM) (WO2021116178A1). -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Fascaplysin
0 ImagesCat. No.: HY-112328CAS No.: 114719-57-2Fascaplysin is an antimicrobial and cytotoxic red pigment, that can come from the marine sponge (Fascaplysinopsis sp.). Fascaplysin has been synthesized in seven steps from indole (65% yield). Fascaplysin can induces apoptosis and autophagy in human leukemia HL-60 cells. Fascaplysin shows anti-tumor activity. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- CDK2-IN-13
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Tambiciclib dimaleate
0 ImagesSynonyms: GFH009 dimaleate; JSH-009 dimaleate; SLS009 dimaleateTambiciclib (GFH009, JSH-009) dimaleate is an orally active, highly potent and selective CDK9 inhibitor (IC50 = 1 nM), demonstrating >200-fold selectivity over other CDKs, >100-fold selectivity over DYRK1A/B, and excellent selectivity over 468 kinases/mutants. Tambiciclib dimaleate demonstrates potent in vitro and in vivo antileukemic efficacy in acute myeloid leukemia (AML) mouse models by inhibiting RNA Pol II phosphorylation, downregulating MCL1 and MYC, and inducing apoptosis. Tambiciclib dimaleate can be used for AML research. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
CK7
0 ImagesCK7, a Cdk2/9 inhibitor, can be used for the synthesis of Nek1 inhibitor BSc5231 and BSc5367. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- CLK1/2-IN-1
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- GSK-3/CDK5/CDK2-IN-1
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- YX0798
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
AG-494
0 ImagesSynonyms: Tyrphostin AG 494 -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
CDK4/6-IN-9
0 ImagesCDK4/6-IN-9 (compound 10) is a selective CDK4/6 inhibitor with an IC50 of 905 nM for CDK6/cyclin D1. CDK4/6-IN-9 has the potential for multiple myeloma (MM) research. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
PP-C8
0 ImagesPP-C8 is a potent and selective PROTAC CDK12-Cyclin K degrader. PP-C8 induces CDK12-Cyclin K degradation with DC50s of 416 and 412 nM for CDK12 and Cyclin K, respectively. PP-C8 demonstrates profound synergistic antiproliferative effects with PARP inhibitor in triple-negative breast cancer (TNBC). -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
No matching results
No matching results
No matching results
No matching results
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
Your Search Returned No Results.
Sorry. There is currently no product that acts on isoform Bcl-2, Bcl-W and Bim together.Please
try each isoform separately.